作者: Patrick M. Lynch , Rodger J. Winn , Michael J. Wargovich , Bernard Levin
DOI: 10.1007/978-4-431-68337-7_29
关键词:
摘要: The UT M. D. Anderson Cancer Center recently initiated a registry for Hereditary Non-polyposis Colorectal (HNPCC). Modelled after the Creighton program, our interests include early detection and clinical management, intermediate laboratory markers, chemoprevention. Kindreds registered to date have usual features of HNPCC. Mucosal markers (tritiated thymidine bromodeoxyuridine labelling) varied considerable amongst high-risk subjects studied. A multi-centered prospective screening trial, with further evaluation chemoprevention strategies is proposed.